Skip to content

The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion

The Relation Between Maternal Serum High Sensitivity C Reactive Protein and Total and Differential Leucocytic Count Levels in Healthy Pregnant Women With Threatened Abortion and the Outcome of Pregnancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05986357
Enrollment
240
Registered
2023-08-14
Start date
2023-07-30
Completion date
2023-10-30
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion Early

Keywords

C reactive protein, total and differential leucocytic count, abortion

Brief summary

to identify the relation between maternal serum high sensitivity C reactive protein and total and differential leucocytic count values in healthy pregnant women with threatened abortion and the outcome of pregnancy

Detailed description

observational prospective cohort research will be pregnant women attending to obstetrics and gynecology department of University Hospital. After enrollment, participants will be divided into two groups: * Study group: had 120 healthy women presenting with threatened miscarriage. * Control group: had 120 healthy women with an uncomplicated single pregnancy. informed permission will be obtained. All cases subjected to the following: taking complete history, General examination, Special investigations including Obstetric ultrasonography for assessment of gestational age, and exclusion of congenital anomalies or multi-fetal gestation. Laboratory investigations including Estimation of the complete blood picture (CBC), Highly sensitive CRP (HS-CRP) single measurement, Women over 1st trimester abdominal ultrasonographic examination (6-13weeks) using Toshiba with transabdominal transducer probe frequency of 7 MHz to evaluate the following data: Measuring of the fetal crown-rump length (CRL) done to confirm the fetal gestational age and the viability of the fetus. Gestational age will be calculated from the beginning of the last regular menstrual cycle. Women who had hormone therapy or progesterone supplements, as well as pregnancies with a discrepancy between LMP and crown rump length of more than three days, were excluded from the research. Pregnant women will be under close follow up every 2 weeks by: Obstetric U/S, Measure blood pressure and inform us if severe bleeding occurs.

Interventions

DIAGNOSTIC_TESTmaternal serum C reactive protein

maternal serum high sensitivity C reactive protein

DIAGNOSTIC_TESTtotal leucocytic count levels

total leucocytic count levels

DIAGNOSTIC_TESTdifferential leucocytic count levels

differential leucocytic count levels

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Single intrauterine pregnancy with vaginal hemorrhage and/or abdominal pain in the study group, * an ultrasound showing an intrauterine gestational sac with a live fetus and a regular fetal heartbeat, with/without a sub-chorionic hematoma, * healthy women who come for routine antenatal care with spontaneous pregnancy.

Exclusion criteria

* Age over 40 * smoking * multiple pregnancies * endocrinological diseases * history of repeated spontaneous abortions.

Design outcomes

Primary

MeasureTime frameDescription
Highly sensitive CRP (HS-CRP)9 monthsA high level of hs-CRP, i.e., greater than 3 mg/L,
total leucocytic count9 monthsmeasures the number of white blood cells (WBCs) in blood

Countries

Egypt

Contacts

Primary ContactBeni-suef University
fom@med.bsu.edu.eg082 2318605

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026